A beloved, family-run wildlife park in the UK is shutting its gates for good after 17 years, citing spiralling costs, ageing ...

At the new Milken Center for Advancing the American Dream, ambition is renewable, optimism is merchandised, and irony remains ...

Broader markets also weakened, with the BSE Midcap index falling 0.74 per cent and the BSE Smallcap index dropping 0.95 per cent. Both benchmark indices declined for the second straight session, ...

Beam Therapeutics (BEAM) has found itself in the spotlight this week as several major banks, including Jefferies and HC Wainwright, initiated or reiterated Buy ratings. These moves followed meaningful ...

Fintel reports that on October 10, 2025, HC Wainwright & Co. reiterated coverage of Beam Therapeutics (NasdaqGS:BEAM) with a Buy recommendation. Analyst Price Forecast Suggests 64.08% Upside As of ...

Investing.com - Jefferies initiated coverage on Beam Therapeutics Inc (NASDAQ:BEAM) with a Buy rating and a price target of $27.00, citing upcoming clinical data catalysts expected in 2025 and 2026.

This article is part of Gizmodo Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Reading time: Reading time 2 minutes Imagine being ...

Construction has started on the first mass timber structure in Columbus, Ohio, planned to stand 13 stories and touted to be the tallest mass timber student housing building in the United States once ...